IL161248A0 - USE OF (11beta,17beta)-11-(1,3-BENZODIOXOL-5-YL) 17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER - Google Patents
USE OF (11beta,17beta)-11-(1,3-BENZODIOXOL-5-YL) 17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDERInfo
- Publication number
- IL161248A0 IL161248A0 IL16124802A IL16124802A IL161248A0 IL 161248 A0 IL161248 A0 IL 161248A0 IL 16124802 A IL16124802 A IL 16124802A IL 16124802 A IL16124802 A IL 16124802A IL 161248 A0 IL161248 A0 IL 161248A0
- Authority
- IL
- Israel
- Prior art keywords
- estra
- benzodioxol
- dien
- propynyl
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204072 | 2001-10-26 | ||
| PCT/EP2002/011732 WO2003037354A1 (en) | 2001-10-26 | 2002-10-21 | USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161248A0 true IL161248A0 (en) | 2004-09-27 |
Family
ID=8181136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16124802A IL161248A0 (en) | 2001-10-26 | 2002-10-21 | USE OF (11beta,17beta)-11-(1,3-BENZODIOXOL-5-YL) 17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER |
| IL161248A IL161248A (en) | 2001-10-26 | 2004-04-01 | Use of (11,17)-11-(1, 3 - benzodioxol-5-yl)-17- hydroxy-17-(1-propynyl)-estra- 4, 9 - dien-3-one for the preparation of a medicament for the treatment of major depressive disorder |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL161248A IL161248A (en) | 2001-10-26 | 2004-04-01 | Use of (11,17)-11-(1, 3 - benzodioxol-5-yl)-17- hydroxy-17-(1-propynyl)-estra- 4, 9 - dien-3-one for the preparation of a medicament for the treatment of major depressive disorder |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20040266863A1 (ko) |
| EP (2) | EP1441739B1 (ko) |
| JP (1) | JP4647909B2 (ko) |
| KR (1) | KR20050038580A (ko) |
| CN (1) | CN100531738C (ko) |
| AT (2) | ATE420649T1 (ko) |
| AU (1) | AU2002348996B2 (ko) |
| BR (1) | BR0213466A (ko) |
| CA (1) | CA2463446C (ko) |
| CY (1) | CY1110173T1 (ko) |
| DE (2) | DE60209248D1 (ko) |
| DK (1) | DK1652526T3 (ko) |
| EC (1) | ECSP045080A (ko) |
| ES (1) | ES2319563T3 (ko) |
| HK (1) | HK1087357A1 (ko) |
| HR (1) | HRP20040370B1 (ko) |
| HU (1) | HUP0500070A3 (ko) |
| IL (2) | IL161248A0 (ko) |
| IS (1) | IS2702B (ko) |
| MX (1) | MXPA04003781A (ko) |
| NO (1) | NO332978B1 (ko) |
| NZ (1) | NZ532429A (ko) |
| PL (1) | PL206687B1 (ko) |
| PT (1) | PT1652526E (ko) |
| RU (1) | RU2302245C2 (ko) |
| WO (1) | WO2003037354A1 (ko) |
| ZA (1) | ZA200403088B (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050080061A1 (en) * | 2003-07-23 | 2005-04-14 | Corcept Therapeutics, Inc. | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| AU2011236053B2 (en) * | 2004-11-19 | 2014-06-26 | Merck Sharpe & Dohme B.V. | Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| US20080255074A1 (en) * | 2004-11-19 | 2008-10-16 | N.V. Organon | Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression |
| CA2649894A1 (en) * | 2006-05-02 | 2007-11-15 | Corcept Therapeutics, Inc. | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
| JP5804395B2 (ja) * | 2011-02-03 | 2015-11-04 | ポップ テスト オンコロジー エルエルシー | 診断と治療のためのシステムおよび方法 |
| WO2012145258A1 (en) * | 2011-04-18 | 2012-10-26 | Pop Test Cortisol Llc | Hair loss treatment |
| US8986677B2 (en) * | 2012-07-30 | 2015-03-24 | Pop Test Cortisol Llc | Therapeutic compositions and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
| IL118974A (en) * | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
| DE19727772A1 (de) * | 1997-06-30 | 1999-01-28 | Forschungszentrum Juelich Gmbh | Magnetflußsensor mit ringförmiger Sonde |
| JP2001518509A (ja) * | 1997-10-06 | 2001-10-16 | ザ ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ | グルココルチコイド関連機能不全に関連した精神病の処置のための方法。 |
| CA2440605C (en) * | 2001-03-23 | 2012-01-10 | Corcept Therapeutics, Inc. | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| NZ529456A (en) * | 2001-05-04 | 2005-10-28 | Corcept Therapeutics Inc | Use of GR antagonists such as RU009 and RU044 to ameliorate the symptoms of delirium |
| ES2314103T3 (es) * | 2001-08-31 | 2009-03-16 | Corcept Therapeutics, Inc. | Metodo para inhibir deterioro cognitivo en adultos con sindrome de down. |
-
2002
- 2002-10-21 HU HU0500070A patent/HUP0500070A3/hu unknown
- 2002-10-21 RU RU2004116082/15A patent/RU2302245C2/ru not_active IP Right Cessation
- 2002-10-21 NZ NZ532429A patent/NZ532429A/en not_active IP Right Cessation
- 2002-10-21 DK DK06101005T patent/DK1652526T3/da active
- 2002-10-21 IL IL16124802A patent/IL161248A0/xx unknown
- 2002-10-21 BR BR0213466-7A patent/BR0213466A/pt not_active IP Right Cessation
- 2002-10-21 PL PL369261A patent/PL206687B1/pl not_active IP Right Cessation
- 2002-10-21 CN CNB028210417A patent/CN100531738C/zh not_active Expired - Fee Related
- 2002-10-21 DE DE60209248T patent/DE60209248D1/de not_active Expired - Lifetime
- 2002-10-21 AT AT06101005T patent/ATE420649T1/de active
- 2002-10-21 PT PT06101005T patent/PT1652526E/pt unknown
- 2002-10-21 EP EP02781273A patent/EP1441739B1/en not_active Withdrawn - After Issue
- 2002-10-21 US US10/493,981 patent/US20040266863A1/en not_active Abandoned
- 2002-10-21 KR KR1020047006050A patent/KR20050038580A/ko not_active Application Discontinuation
- 2002-10-21 EP EP06101005A patent/EP1652526B1/en not_active Expired - Lifetime
- 2002-10-21 DE DE60230936T patent/DE60230936D1/de not_active Expired - Lifetime
- 2002-10-21 JP JP2003539697A patent/JP4647909B2/ja not_active Expired - Fee Related
- 2002-10-21 AT AT02781273T patent/ATE317700T1/de active
- 2002-10-21 WO PCT/EP2002/011732 patent/WO2003037354A1/en not_active Application Discontinuation
- 2002-10-21 ES ES06101005T patent/ES2319563T3/es not_active Expired - Lifetime
- 2002-10-21 CA CA2463446A patent/CA2463446C/en not_active Expired - Fee Related
- 2002-10-21 MX MXPA04003781A patent/MXPA04003781A/es active IP Right Grant
- 2002-10-21 AU AU2002348996A patent/AU2002348996B2/en not_active Ceased
-
2004
- 2004-03-31 IS IS7204A patent/IS2702B/is unknown
- 2004-04-01 IL IL161248A patent/IL161248A/en not_active IP Right Cessation
- 2004-04-22 ZA ZA200403088A patent/ZA200403088B/en unknown
- 2004-04-23 NO NO20041651A patent/NO332978B1/no not_active IP Right Cessation
- 2004-04-23 EC EC2004005080A patent/ECSP045080A/es unknown
- 2004-04-26 HR HRP20040370AA patent/HRP20040370B1/xx not_active IP Right Cessation
-
2006
- 2006-08-29 HK HK06109619.6A patent/HK1087357A1/xx not_active IP Right Cessation
-
2009
- 2009-02-02 CY CY20091100116T patent/CY1110173T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1087357A1 (en) | Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder. | |
| UA83620C2 (ru) | Замещенные бензоксазолы и их аналоги как эстрогенные агенты | |
| CY1104981T1 (el) | Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων | |
| PL345955A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL | |
| ES2124905T3 (es) | Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad. | |
| SG153645A1 (en) | Hormone replacement therapy | |
| MXPA04005784A (es) | 2-fenilbenzofuranos sustituidos como agentes estrogenitos. | |
| IL159714A (en) | Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac | |
| HUP0500346A2 (hu) | Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására | |
| HUP0402028A3 (en) | Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof | |
| IL133632A (en) | Use of a specific 5ht2 receptor antagonist for the preparation of pharmaceutical compositions useful in the treatment of the sleep apnea syndrome | |
| MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
| WO2002074315A8 (de) | Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie | |
| EA200501739A1 (ru) | Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний | |
| RS50350B (sr) | Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma | |
| HK1070900A1 (en) | Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds | |
| ZA200110073B (en) | 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments. | |
| YU30103A (sh) | Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti | |
| NO20022712D0 (no) | Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene | |
| BR0304292A (pt) | Preparado de combinação de estrogênio-gestagênio e uso |